- Exchange: Oslo
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Drug Delivery Systems
PCI Biotech Holding ASA
Add to PortfolioPCIB:NO
36.00 NOK 0.000.00%As of 11:25:18 ET on 05/29/2012.
Snapshot for PCI Biotech Holding ASA (PCIB)
| Open: | 36.00 | Day's Range: | 36.00 - 36.00 | Volume: | 150 | Bid: | 37.00 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 36.00 | 52wk Range: | 32.00 - 58.50 | 1-Yr Rtn: | -25.00% | Ask: | 38.80 |
Key Statistics for PCIB
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share (NOK) (ttm) | -2.0864 |
| Est. EPS (NOK) (12/2012) | -3.9000 |
| Est. PEG Ratio | - |
| Market Cap (M NOK) | 275.99 |
| Shares Outstanding (M) | 7.67 |
| Enterprise Value (M NOK) (ttm) | 180.88 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 2.8642 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/21/2012 |
More PCIB Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for PCIB
- Operating
- Investing
- Financing (M/NOK)
Company Profile & Key Executives for PCIB
PCI Biotech AS is a biotechnology company. The Company develops photochemical drug delivery technology for treatment in cancer therapy.
| Erling OeverlandChairman | Per WaldayChief Executive Officer |
| Bernt-Olav RottingsnesChief Financial Officer | Anders HogsetChief Scientific Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page